Chemed Corporation

CHENYSEHealthcare● Active

$440.65

$-0.95(-0.21%)

Market Cap$5.8B

P/E Ratio—

52W High$565.66

52W Low$365.21

Avg Volume255K

Open$433.76

Beta0.54

Overview

Chemed Corporation（CHE）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

che · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 9 位华尔街分析师

Hold

9 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 9 · 买入占比: 44.4%

12 个月目标价

High

$475

Consensus

$475

+7.6% upside

Low

$475

Median: $475 · Last Close: $441.59

Chemed Corporation（CHE）的分析师共识为 Hold，基于过去 3 个月内 9 位华尔街分析师的评级。CHE 的 12 个月平均目标价为 $475.00，相对当前价 $441.59 代表 +7.6% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$438.62	↓ 0.67%	$437.73	$439.51

1-day model range: $437.73–$439.51. Peak: $439.51 (-0.67%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$501	$506	$512	+14.7%
2028	$542	$551	$560	+24.8%
2029	$569	$580	$591	+31.4%
2030	$585	$599	$612	+35.5%
2031	$595	—	$625	+38.1%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%

13Buy

1Neutral

0Sell

RSI (14)55.5Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CHE · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$428.17BUY

MA 10$432.32BUY

MA 20$431.91BUY

MA 50$410.01BUY

MA 100$420.53BUY

MA 200$431.00BUY

Current $CHE · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$432.82BUY

EMA 10$431.96BUY

EMA 20$429.24BUY

EMA 50$420.90BUY

EMA 100$422.14BUY

EMA 200$438.93BUY

Current $CHE · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-04-27	RBC Capital	Maintains	Sector Perform→Sector Perform
2026-02-27	Oppenheimer	Maintains	Outperform→Outperform
2026-02-27	RBC Capital	Downgrade ↓	Outperform→Sector Perform
2026-01-22	Jefferies	Downgrade ↓	Buy→Hold
2025-11-10	RBC Capital	Maintains	Outperform→Outperform
2025-09-10	B of A Securities	Maintains	Buy→Buy
2025-09-02	Jefferies	Upgrade ↑	Hold→Buy
2025-07-31	RBC Capital	Maintains	Outperform→Outperform
2025-07-31	Oppenheimer	Maintains	Outperform→Outperform
2025-06-30	RBC Capital	Maintains	Outperform→Outperform

RBC Capital2026-04-27

Maintains

Sector Perform→Sector Perform

Oppenheimer2026-02-27

Maintains

Outperform→Outperform

RBC Capital2026-02-27

Downgrade ↓

Outperform→Sector Perform

Jefferies2026-01-22

Downgrade ↓

Buy→Hold

RBC Capital2025-11-10

Maintains

Outperform→Outperform

B of A Securities2025-09-10

Maintains

Buy→Buy

Jefferies2025-09-02

Upgrade ↑

Hold→Buy

RBC Capital2025-07-31

Maintains

Outperform→Outperform

Oppenheimer2025-07-31

Maintains

Outperform→Outperform

RBC Capital2025-06-30

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Chemed Corporation (CHE) stock. Of the recent 49 rating actions, 3 were upgrades and 4 were downgrades. 9 analysts currently cover CHE.

分析师推荐趋势

Buy ratings2 → 0↓ 2

Hold ratings0 → 1↑ +1

Sell ratings0 → 0

CHE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2.4B

↓ 9.8% YoY

Revenue Next Year

$2.5B

↑ 5.0% YoY

EPS This Year

$23.08

EPS Next Year

$22.15

↓ 4.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CHE EPS of $23.08 for the current fiscal year, based on estimates from 2 analysts. The CHE revenue forecast is $2.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CHE 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CHE 的共识目标价为 $475.00（+7.6% 上行空间），分析师共识为 Hold。

CHE 的短期预测（明日）为 $438.62（-0.67%）。 CHE 对 2027 年的股价预测均值为 $506。 CHE 对 2030 年的预测区间为 $585–$612。

Chemed Corporation 在 NYSE 上市，代码 CHE。CHE 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 44% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CHE 预测 · 8 个问题

根据 9 位华尔街分析师，CHE 的 12 个月平均目标价为 $475.00，最高 $475.00、最低 $475.00。若有图表，中位目标价可在上方查看。相对当前价 $441.59，隐含约 +7.6% 的上行空间。

CHE 目标价CHE 分析师目标价CHE 12个月目标价目标价 CHE

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.